close
close

Good information for the affected person: Better therapy after alternating health care

Good information for the affected person: Better therapy after alternating health care

A new clinical study may benefit many people with chronic herzschwäche treatments. An international science team under the Beteiligung van Experten of the MedUni Graz has the right to spend a time when using medication by resensitivity patients on the häufigsten Form der Erkrankung im Alter werk.

In Austria, 160,000 people are affected by chronic hernia. Leistungsverlust, Kurzatmigkeit and Flussigkeitsrückstau can use the life-giving Komplikationen führen. If a pump insufficiency of the linked Herzkammer no longer works, Blut may be expanded (sometimes the outflow fraction is removed), while this function is reduced to a greater or greater extent. The high form of the chronic herze is one of the few distortions made before the coupling of the Herzkammer before Blutes. Commitment to all other people will often lead to women. The background of the form of the Erkrankung is one of the reinforcements of the coupling herzkammer, but if the “new” Blut is not displayed, it is pumped further.

If you are concerned with the treatment of analysis in the early years, it is a new Platz for Fortschritte, which (October 24) from the American cardiologist Scott Solomon (Brigham and Women’s Hospital of Harvard Medical School/Boston) and his Co -Autoren im weltweit angesehensten Medizin-Fachjournal “New England Journal of Medicine” (DOI: 10.1056/NEJMoa2407107).

For the medical treatment of chronic retreatment, there is actually an age-old drug therapy with the sogenante ACE-Hemmern, beta blockers and entwässerungsmitteln (diuretics). Ensure that the affected minerals do not contain any mineral short inhibitors. They ensure that the hormone aldosterone is absorbed into the body and that it has an enhanced effect caused by the herz. There is an anti-effective effect. One solution to solving problems is that it can be refined for a long time.

“Mineral corticoid receptor antagonists alleviate the disease and mortality in herzschwächepatients with verringer Auswurfleistung des Herzens, the effect is now little verringerter or erhaltener Ejektionsfraction wurde aber noch nicht ininvested (…)”, writes the Wissenschafter. They are planning a large international study into a refined study with their son’s therapy and with Placebo-Gruppen-Vergleich.

The Probanden must lead a Herzschwäche with erhaltener or wenig reduzierter Ejektionsfraktion der linken Herzkammer. Half of the probands are combined with the tested medication (maximum 20 or 40 milligrams finer per tag), the other half on a placebo. Insgesamt nahmen 6.001 Patients an der Untersuchung teil.

De mittlere Beobachtungszeit der Patients betrug 32 Monate. What matters is that both tire groups of a number of plants are Spitalsaufenthalten or Notfallambulanzbesuchen roads Herzschwäche and/or of Herz-Kreislauf-Todesfällen comb. The ergebnisse seems to put an end to a treatment of the treatment of fine patients with non-existent treatment of the brain.

In the Gruppe, where the real medicine is so good, it is about 16 percent of the expenditure on health care and recovery-Kreislauf-Todesfälle in the Placebo-Gruppe. This war is statistically significant. In some plants, hospital admissions and notambulatory frequencies are a reduction of a significant statistical value of 18 Prozent. With the Nebenwirkungen it is true that the Vergleichsgruppen are not wesentlichen Unterschiede. The processing of veneers in the sick with constant revision cannot take longer in the future.